Endoluminal treatment of Barrett's esophagus: Current and future prospects

Therapeutic Advances in Gastroenterology

Volumn 2, Issue 5, 2009, Pages 261-272

  Smith, Michael S ^a   Lightdale, Charles J ^b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Medicine   (United States)

Author keywords

Barrett's esophagus; Esophageal cancer; Therapeutics

Indexed keywords

LIQUID NITROGEN;

ARGON PLASMA COAGULATION; BARRETT ESOPHAGUS; CAUTERIZATION; CRYOABLATION; CRYOTHERAPY; ENDOLUMINAL TREATMENT; ENDOSCOPIC SURGERY; ESOPHAGUS SURGERY; HUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; SURGICAL APPROACH; SURGICAL TECHNIQUE;

EID: 77953461962     PISSN: 1756283X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1756283X09338236     Document Type: Review

References (42)

1. Anandasabapathy, S., Maru, D., Klumpp, S.A., Uthamanthil, R., Borne, A. and Bhutani, S. ( 2008) Novel endoscopic application of a new flexible fiber CO 2 laser for esophageal mucosal ablation. Gastrointest Endosc 67: AB145.
2. Badreddine, R.J., Wang, K.K., Prasad, G.A., Buttar, N., Song, L.M.W.K., Lutzke, L.S. et al. (2008 a) Recurrence of neoplasia after ablation of Barrett's esophagus (BE). Gastrointest Endosc 67 (5): AB176.
3. Badreddine, R.J., Wang, K.K., Prasad, G.A., Song, L.M.W.K., Buttar, N., Borkenhagen, L.S. et al. (2008 b) Does endoscopic mucosal resection (EMR) affect subsequent esophagectomy? Gastrointest Endosc 67: AB177.
4. Badreddine, R.J., Wang, K.K., Prasad, G.A., Song, L.M.W.K., Westra, W., Buttar, N. et al. (2008 c) Confocal laser microscopy (CLM) guided endoscopic mucosal resection in Barrett's esophagus with high grade dysplasia. Gastrointest Endosc 67 (5): AB179.
5. Beaumont, H., Gondrie, J.J., McMahon, B.P., Gregersen, H., Rosmolen, W., Bergman, J.J. et al. (2008) Stepwise circumferential and focal radiofrequency ablation of Barrett's esophagus preserves esophageal diameter, compliance and motility. Gastroenterology 134(Suppl. 1): A434-.
6. Bhat, Y.M., Brensinger, C.M. and Ginsberg, G.G. ( 2008) Endoluminal resection (ELR) with the Duette multi-band mucosectomy system is safe, efficacious and enhances diagnosis and staging in highly dysplastic Barrett's. Gastrointest Endosc 67: AB188.
7. Bumgarner, J.M., Panjehpour, M., Long, M., Dellon, E.S., Overholt, B.F. and Shaheen, N.J. ( 2008) Comparison of catheter-based radiofrequency ablation and photodynamic therapy for Barrett's esophagus. Digestive Disease Week 2008. Gastroenterology 134(Suppl. 1): A436-.
8. Canto, M.I., Dunbar, K.B., Okolo, P., Jagannath, S.B. and Kantsevoy, S.V. ( 2008) Low flow CO2-cryotherapy for high risk Barrett's esophagus (BE) patients with high grade dysplasia and early adenocarcinoma: a pilot trial of feasibility and safety. Gastrointest Endosc 67: AB179-AB180.
9. Chennat, J.S., Konda, V.J., Ross, A.S., Herreros de Tejada, A., Cislo, B.M., Stearns, L. et al. (2008 a) Correlation of Barrett's histological surveillance biopsies versus final endoscopic mucosectomy resection (EMR) specimens: are we seeing the forest or just the trees? Gastrointest Endosc 67: AB171-AB172
10. Chennat, J.S., Konda, V.J., Ross, A.S., Herreros de Tejada, A., Cislo, B.M., Stearns, L. et al. (2008 b) Safety profile of single session complete Barrett's esophagus endoscopic mucosal resection (CBD-EMR). Gastrointest Endosc 67: AB172.
11. Deprez, P.H., Yeung, R.C., Aouattah, T., Sempoux, C. and Piessevaux, H. ( 2008) Prospective randomized comparison between EMR and ESD for endoscopic removal of superficial esophageal cancer. Gastrointest Endosc 67: AB187.
12. Dumot, J.A., Vargo, J.J., Zuccaro, G., Falk, G.W., Frey, L. and Rice, T. ( 2008) Results of cryospray ablation for esophageal high grade dysplasia (HGD) and intramucosal cancer (IMCA) in high risk non-surgical patients. Gastrointest Endosc 67: AB176.
13. Finkelstein, S.D. and Lyday, W.D. ( 2008) The molecular pathology of radiofrequency mucosal ablation of Barrett's esophagus. Gastroenterology 134(Suppl. 1): A436-.
14. Fukami, N., Dekovich, A.A., Sericati, M.R., Maru, D., Wang, H. and Hofstetter, W.L. ( 2008) Multifocal high-grade dysplasia (MFHGD) in Barrett's esophagus is associated with adenocarcinoma in patients undergoing endoscopic mucosal resection (EMR) for Barrett's esophagus. Gastrointest Endosc 67: AB180.
15. Gondrie, J.J., Seewald, S., Pouw, R.E., Piessavaux, H., Deprez, P.H., Pohl, H. et al. (2008) Stepwise radical endoscopic resection for complete removal of Barrett's esophagus with early neoplasia: an international multicenter study. Gastrointest Endosc 67: AB175-AB176
16. Gostout, C.J. ( 2008) Technique and instrumentation for sub-mucosal endoscopy with mucosal resection (SEMR). Gastrointest Endosc 67: AB148.
17. Greenwald, B.D., Horwhat, J.D., Abrams, J.A., Lightdale, C.J. and Dumot, J.A. ( 2008) Endoscopic cryotherapy ablation is safe and well-tolerated in Barrett's esophagus, esophageal dysplasia and esophageal cancer. Gastrointest Endosc 67: AB76.
18. Gross, S.A., Gill, K.R., Greenwald, B.D. and Wolfsen, H.C. ( 2008) Burn, freeze or photo-ablate? Comparative symptom profile in patients with Barrett's high grade dysplasia undergoing endoscopic ablation. Gastrointest Endosc 67: AB180-AB181
19. Hernandez, J.C., Chung, D.S., Pham, B.V., Reicher, S., Tsai, F., Chahal-Sekhon, N. et al. (2008) Interim analysis of Barrett's esophagus eradication by radiofrequency ablation. Gastrointest Endosc 67: AB180.
20. Ishii, N., Tsukamoto, M., Izuka, Y., Fukuda, K., Yamazaki, K., Kumakura, Y. et al. (2008) Endoscopic submucosal dissection is a safe and effective treatment for superficial esophageal cancer. First results in a primary hospital. Gastrointest Endosc 67: AB184.
21. Lightdale, C.J., Overholt, B.F., Wang, K.K., Mashimo, H., Sharma, V.K., Fleischer, D.E. et al. (2008) Predictors of quantitative assessment of incomplete response after radiofrequency ablation for dysplastic Barrett's esophagus: analysis of randomized sham-controlled clinical trial (the AIM Dysplasia trial). Gastrointest Endosc 67: AB182.
22. Manner, H., May, A., Pech, O., Gossner, L., Rabenstein, T., Vieth, M. et al. (2008) Are patients with ‘low risk’ submucosal invasion of early Barrett's carcinoma eligible for curative endoscopic therapy? Outcomes of endoscopic therapy and surgery in 80 patients with suspected or definite diagnosis of submucosal Barrett's cancer. Gastrointest Endosc 67: AB75-AB76
23. Muthusamy, R., Rastogi, A., Edmundowicz, S.A., Shaheen, N.J., Sharma, P. and Chang, K. ( 2008) The utility of endoscopic ultrasound (EUS) in patients with Barrett's esophagus (BE) and high grade dysplasia (HGD): analysis of the AIM Dysplasia trial experience. Gastrointest Endosc 67: AB99.
24. Piraka, C.R., Elmunzer, B.J., Kwon, R.S. and Rubenstein, J.H. ( 2008) Invasive cancer in endoscopic mucosal resection specimens of non-nodular Barrett's esophagus: implications for ablative therapy. Gastrointest Endosc 67: AB178.
25. Pouw, R.E., Gondrie, J.J., Alvarez Herrero, L., van Vilsteren, F.G., Peters, F., Rosmolen, W. et al. (2008 a) A randomized prospective trial comparing the cap-technique and multi-band mucosectomy technique for piecemeal endoscopic resection in Barrett's esophagus. Gastrointest Endosc 67: AB75.
26. Pouw, R.E., Gondrie, J.J., van Vilsteren, F.G., Sondermeijer, C., Rosmolen, W., Curvers, W.L. et al. (2008 b) A promising new combined treatment modality for Barrett's esophagus containing early neoplasia: endoscopic resection followed by step-wise circumferential and focal radiofrequency energy ablation. Gastrointest Endosc 67: AB181.
27. Pouw, R.E., Gondrie, J.J., van Vilsteren, F.G., Sondermeijer, C., Rosmolen, W., Curvers, W.L. et al. (2008 c) Complications following circumferential radiofrequency energy ablation of Barrett's esophagus containing early neoplasia. Gastrointest Endosc 67: AB145.
28. Pouw, R.E., Gondrie, J.J., van Vilsteren, F.G., Sondermeijer, C., Rosmolen, W., Curvers, W.L. et al. (2008 d) Stepwise circumferential and focal radiofrequency ablation of Barrett's esophagus with high-grade dysplasia or intramucosal cancer. Gastroenterology 134(Suppl. 1): A-844.
29. Prasad, G.A., Halling, K.C., Brankley, S.M., Buttar, N., Song, L.M.W.K., Zinsmeister, A.R. et al. (2008) Biomarker status post ablation can predict recurrent dysplasia in Barrett's esophagus: a prospective study. Gastroenterology 134(Suppl. 1): A-434.
30. Rastogi, A., Bansal, A., Olyaee, M.S., Wani, S.B., Pondugula, K., Higbee, A.D. et al. (2008) Should endoscopic ultrasonography (EUS) be performed in Barrett's esophagus (BE) patients with flat high grade dysplasia and/or mucosal adenocarcinoma? Gastroenterology 134(Suppl. 1): A-380.
31. Sayana, H., Wani, S.B., Keighley, J.D., Bansal, A., Rastogi, A., Mathur, S.C. et al. (2008) Endoscopic mucosal resection (EMR) as a diagnostic tool in Barrett's esophagus (BE) patients with high-grade dysplasia (HGD) and early esophageal adenocarcinoma (EAC): a systematic review. Gastroenterology 134(Suppl. 1): A-724.
32. Shaheen, N.J., Bronner, M.P., Fleischer, D.E., Rothstein, R.I., Sharma, V.K., Lightdale, C.J. et al. (2008 a) Subsquamous intestinal metaplasia is a common finding in ablation-naïve patients with dysplastic Barrett's esophagus, and significantly decreases in prevalence after radiofrequency ablation. Gastrointest Endosc 67: AB176.
33. Shaheen, N.J., Goldblum, J.R., Sampliner, R.E., Chak, A., Wang, K.K., Fennerty, M.B. et al. (2008 b) Are biopsies after ablation for dysplastic Barrett's esophagus of adequate depth to detect glandular mucosa beneath the neosquamous epithelium? Comparative histopathological outcomes from a randomized, sham-controlled trial (AIM Dysplasia trial). Gastroenterology 134(Suppl. 1): A-724.
34. Shaheen, N.J., Sharma, P., Overholt, B.F., Lightdale, C.J., Wolfsen, H.C., Sampliner, R.E. et al. (2008 c) A randomized, multicenter, sham-controlled trial of radiofrequency ablation (RFA) for subjects with Barrett's esophagus (BE) containing dysplasia: interim results of the AIM Dysplasia trial. Gastroenterology 134(Suppl. 1): A-237.
35. Shaheen, N.J., Sharma, P., Overholt, B.F., Lightdale, C.J., Wolfsen, H.C., Sampliner, R.E. et al. (2008 d) A randomized, multicenter, sham-controlled trial of radiofrequency ablation (RFA) for subjects with Barrett's esophagus (BE) containing dysplasia: interim results of the AIM Dysplasia trial. Data from oral presentation #213, Digestive Disease Week 2008, San Diego, CA.
36. Siddiqui, J. and Gerke, H. ( 2008) Efficacy and safety of band ligator assisted mucosal resection to completely remove Barrett's esophagus with high grade dysplasia or early cancer. Gastrointest Endosc 67: AB177.
37. Smith, M.S. and Lightdale, C.J. ( 2008) Barrett's oesophagus and the increasing role of endoluminal therapy. Ther Adv Gastroenterol 1: 121-142.
38. Stadlhuber, R.J., Yano, F., Penka, W.E., Mittal, S.K., Rothstein, R.I. and Filipi, C.J. ( 2008) A new method for Barrett's mucosal excision. Gastrointest Endosc 67: AB147.
39. Wang, K.K., Badreddine, R.J., Prasad, G.A., Buttar, N., Westra, W., de Mars, C.J. et al. (2008) Cell senescence as a potential mechanism of p 16 mediated resistance to ablation of Barrett's esophagus (BE) in vivo. Gastroenterology 134(Suppl. 1): A-79.
40. Wani, S.B., Sampliner, R.E., Bansal, A., Rastogi, A., Mathur, S.C., Higbee, A.D. et al. (2008) Thermal ablation of Barrett's esophagus: a 6 year follow-up. Gastroenterology 134(Suppl. 1): A-321.
41. Whang, C.S., Lee, C.E., Nguyen, T.T.H., Lee, J.G., Chang, K. and Muthusamy, R. ( 2008) In patients with Barrett's esophagus (BE) and high grade dysplasia (HGD), does endoscopic ultrasound (EUS) provide additional information beyond esophagogastroduodenoscopy (EGD) alone? Gastrointest Endosc 67: AB199.
42. Wood, R.K., Bhat, Y.M. and Ginsberg, G.G. ( 2008) Application of Duette multi-band mucosectomy for endoluminal resection in the United States. Gastrointest Endosc 67: AB181.